首页> 外文会议>Proceedings of the Sixth Asian symposium on research reactors >Boron Neutron Capture Therapy-Recent Aspect, a change from Thermal Neutron to Eptithermal Neutron Beam and a new protocol
【24h】

Boron Neutron Capture Therapy-Recent Aspect, a change from Thermal Neutron to Eptithermal Neutron Beam and a new protocol

机译:硼中子俘获疗法的最新进展,从热中子到高温中子束的转变以及新协议

获取原文
获取原文并翻译 | 示例

摘要

SInce 1968, One-hundred seventy three patients with glioblastoma, anaplastic astrocytoma , low grade astrocytoma or other types of tumor were treated by boron-neutron capture therapy using a combination of thermal neutron and BSH is 5 reactors. Out of 101 patients with glioma treated by BNCT under the recent protocol, 33 patients lived or have lived longer than 3 years. Nine of these 33 lived or have lived longer than 10 years. According to the retrospective analysis, the important factors related to e clinical results were tumor dose radiation dose and maximum radiation dose in the normal brain cortex. The result was not satisfied as it was expected. Then, we decided to introduce mixed beams which contain thermal neutron and epithermal neutron beams. KUR was reconstructed in 1996 and developed to be availlable to use mixed beams. Following the shutdown of the JRR-2, JRR-4 was reneweed for medical use in 1998. BOth reactors ahve capacity to yield thermal neutron beam, epithermal neutron beam and mixed beams. The development of the neutron source lead us to make a new protocol.
机译:自1968年以来,对173例胶质母细胞瘤,间变性星形细胞瘤,低度星形细胞瘤或其他类型肿瘤的患者采用硼中子俘获疗法,结合热中子和BSH 5反应堆进行治疗。根据最近的协议,在接受BNCT治疗的101例神经胶质瘤患者中,有33位患者的生存期或寿命超过3年。这33个人中有9个人居住或居住超过10年。根据回顾性分析,与临床结果相关的重要因素是正常大脑皮层中的肿瘤剂量辐射剂量和最大辐射剂量。结果不符合预期。然后,我们决定引入包含热中子和超热中子束的混合束。 KUR于1996年进行了重建,并发展为可使用混合梁。随着JRR-2的停产,JRR-4于1998年进行了医疗更新。这两个反应堆均具有产生热中子束,超热中子束和混合束的能力。中子源的发展使我们制定了新的协议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号